Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Amphastar Pharmaceuticals, Inc. First Quarter Earnings Call.
Amphastar Pharmaceuticals Inc. (AMPH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Portolan Capital Management George Mccabe | 340,593 | $12,772,238 | +26% | 1.21% |
| 2. | D E Shaw D. E. Shaw | 137,313 | $5,149,238 | +137% | 0% |
| 3. | AQR Capital Management Cliff Asness | 110,887 | $4,158,263 | -2% | 0% |
| 4. | Point72 Asset Management Steve Cohen | 65,418 | $2,453,168 | 0% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 64,209 | $2,407,839 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.26 | 1,000 | Director | 13,151 | 2020-08-14 | Filing | |
| $16.06 | 15,000 | Large Shareholder, Officer, Director | 2,080,619 | 2018-05-16 | Filing | |
| $16.08 | 25,000 | Large Shareholder, Officer, Director | 2,065,619 | 2018-05-15 | Filing | |
| $10.84 | 6,000 | Director | 101,215 | 2014-08-25 | Filing | |
| $10.00 | 3,500 | Director | 17,639 | 2014-08-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.35 | 10,500 | Officer, Director | 105,148 | 2023-05-18 | Filing | |
| $44.21 | 10,000 | Officer | 87,598 | 2023-05-18 | Filing | |
| $44.01 | 4,519 | Director | 4,163 | 2023-05-18 | Filing | |
| $43.13 | 5,000 | Director | 80,117 | 2023-05-17 | Filing | |
| $43.15 | 1,500 | Director | 8,682 | 2023-05-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 6,567,076 | $246,265,353 | 0% | |
| 2. | 3,386,613 | $126,997,988 | 0.31% | |
| 3. | 2,650,719 | $99,401,964 | 0% | |
| 4. | 1,917,571 | $71,909,496 | 0.02% | |
| 5. | 1,359,495 | $50,981,063 | 0% |
News See All
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Amphastar Pharmaceuticals Fourth Quarter Earnings Call. At this time all participants are in a listen-only mode.
5 Cheap Healthcare Stocks To Invest In
Patterson Companies, Inc. (NASDAQ:PDCO) is a medical supplies company primarily focused on veterinary and delta health products.
Value Hedge Funds are Winning in 2022 Thanks to These 15 Stocks
In this article, we discuss the value hedge funds winning in 2022 and the 15 stocks that helped them do it.
15 Best Drug Stocks To Buy Now
The pharmaceutical industry is thriving globally, and it was given a healthy boost by the COVID-19 vaccine rollouts around the world.
10 Best Pharmaceutical Stocks to Buy in 2022
In this article, we discuss the 10 best pharmaceutical stocks to buy in 2022.
Where Do Hedge Funds Stand On Amphastar Pharmaceuticals Inc (AMPH)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Amphastar Pharmaceuticals Inc (AMPH): Hedge Funds In Wait-and-See Mode
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Here is What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH)
A whopping number of 13F filings filed with U.S.
Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy?
Is Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.
Billionaire Hedge Funds
